BeyondSpring Inc.   NASDAQ (BYSI)

14.35    $1.07   8.06%
At close   Friday, Nov 26 04:00 PM

BeyondSpring Inc. Chart

BYSI Stock Price Today

BeyondSpring Inc. (BYSI) stock rallied over 8.06% intraday to trade at $14.35 a share on NASDAQ. The stock opened with a gain of 2.94% at $13.67 and touched an intraday high of $14.70, rising 10.69% against the last close of $13.28. The stock went to a low of $13.53 during the session.

Stock Snapshot

13.28
Prev. Close
13.67
Open
564.24M
Market Cap
39.01M
Number of Shares
13.53
day Low
14.70
Day High
14.35
-
P/E ratio
39.89%
Free Float in %
-1.92
EPS (TTM)
1.42
Book Value per Share
1.94
Cash Flow per Share
1.48M
Volume

BeyondSpring Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-11-24$12.66$13.28$13.48$12.10884,000
2021-11-23$12.93$12.66$13.01$12.21918,400
2021-11-22$13.37$12.92$13.67$12.90728,900
2021-11-19$13.35$13.25$13.77$13.03589,500
2021-11-18$14.03$13.32$14.06$12.96939,400
2021-11-17$14.25$13.95$15.01$13.90629,000
2021-11-16$14.75$14.28$14.75$13.86545,800
2021-11-15$14.79$14.82$15.41$14.55473,500
2021-11-12$15.01$14.80$15.12$14.66462,600
2021-11-11$14.75$14.93$15.15$14.30472,800
2021-11-10$15.33$14.69$15.50$14.64382,400

Contact Details

28 Liberty Street
39th Floor
New York, NY 10005
United States
http://www.beyondspringpharma.com
646 305 6387

Company Information

Employees61
Beta1.01
Sales or Revenue900000.00
5Y Sales Change-%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development and commercialization of immuno-oncology cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and developing Plinabulin, which is in Phase III clinical trial for the treatment of later-stage non-small cell lung cancer (NSCLC). It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. BeyondSpring Inc. has collaboration agreements with the Fred Hutchinson Cancer Research Center and the University of Washington. The company was founded in 2010 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current BeyondSpring Inc. (BYSI) stock price?

BeyondSpring Inc. (NASDAQ: BYSI) stock price is $14.35 as of the last check on Friday, Nov 26. During the trading session, BYSI stock reached the peak price of $14.70 while $13.53 was the lowest point it dropped to.

BYSI's industry and sector of operation?

The NASDAQ listed BYSI is part of Biotechnology industry that operates in the broader Healthcare sector. BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development and commercialization of immuno-oncology cancer therapies.

Who are the executives of BYSI?

Dr. Lan Huang
Co-Founder, Chairman & CEO

Ms. Elizabeth Adkins Czerepak
Chief Financial Officer

Mr. Richard J. Daly M.B.A.
Chief Operating Officer

Dr. G. Kenneth Lloyd
Chief Scientific Officer


What is the BYSI stock price today?

BYSI stock traded closed the last session at $14.35, which is $1.07 or 8.06% higher than its previous close of $13.28. BYSI's current trading price is -56.52% lower than its 52-week high of $33.00 where as its distance from 52-week low of $8.90 is 61.24%.

How many employees does BYSI have?

Number of BYSI employees currently stands at 61. BYSI operates from 28 Liberty Street 39th Floor New York, NY 10005 United States.

Link for BYSI official website?


How do I contact BYSI?

BYSI could be contacted at 28 Liberty Street 39th Floor New York, NY 10005 United States, or at phone # 646 305 6387 and can also be accessed through its website: http://www.beyondspringpharma.com

How many shares of BYSI are traded daily?

BYSI stock volume for the day was 1.48M shares while in the previous session number of BYSI shares traded was 884000. The average number of BYSI shares traded daily for last 3 months was 1.10M.

How much did BYSI change today?

The percentage change in BYSI stock occurred in the recent session was 8.06% while the dollar amount for the price change in BYSI stock was $1.07.

What price range BYSI stock been trading in?

In the recent session, the day high for BYSI stock was $14.70 while the low for BYSI stock touched on the day was $13.53.

What is the market cap of BYSI currently?

The market value of BYSI currently stands at $564.24M with its latest stock price at $14.35 and 39.01M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam